kyron.bio
kyron.bio uses precision glycan engineering to enhance antibody and protein therapeutics. Their platform controls glycosylation patterns to improve efficacy, safety, and manufacturability—delivering advanced biologics with better patient outcomes.
Founders
Emilia McLaughlin
Cofounder
Emilia holds a PhD in Cell and Molecular Biology from Institut Pasteur and brings over six years of experience researching evolutionarily diverse life forms. She has been awarded multiple research grants and has co-authored five scientific publications, including two as first author.
Vaibhav Longani
Cofounder
Vaibhav holds a Master’s in Business Administration and a Bachelor’s in Electronics and Communication. Before joining Entrepreneurs First and cofounding kyron.bio, he was a consultant at Simon-Kucher & Partners specializing in medtech.